BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Ophthotech Corporation 

5 Vaughn Drive
Suite 106
Princeton  New Jersey  08540  U.S.A.
Phone: 609-945-6050 Fax: 609-452-7435


SEARCH JOBS










 Company News
Ophthotech Corporation (OPHT) To Present At The Stifel 2014 Healthcare Conference 11/13/2014 10:48:39 AM
Ophthotech Corporation (OPHT) Provides Business Update And Reports Third Quarter 2014 Financial Results 11/11/2014 9:19:28 AM
AVEO Oncology (AVEO), Ophthotech Corporation (OPHT) Forge Research, License Deal Worth $105 Million+ 11/11/2014 7:03:37 AM
Ophthotech Corporation (OPHT) To Announce Third Quarter 2014 Financial Results And Host Conference Call On Tuesday, November 11, 2014 11/3/2014 10:01:59 AM
Ophthotech Corporation (OPHT) Names Todd N. Smith As Chief Commercial Officer 10/3/2014 8:15:34 AM
Ophthotech Corporation (OPHT) Names Michael G. Atieh As Executive Vice President And Chief Financial And Business Officer 9/23/2014 9:49:10 AM
Ophthotech Corporation (OPHT) Announces Fovista® Phase 2b Independent Analysis Shows That Fovista® Anti-PDGF Therapy, Combined With Anti-VEGF Therapy, Is Associated With A Reduction Of Sub-Retinal Fibrosis In Wet AMD Patients 9/16/2014 9:12:28 AM
Ophthotech Corporation (OPHT) Banks $50 Million Milestone From Novartis AG (NVS) For Fovista® Pact 9/8/2014 6:05:20 AM
Ophthotech Corporation (OPHT) To Present At The 2014 Morgan Stanley (MST) Global Healthcare Conference 9/2/2014 1:41:48 PM
Ophthotech Corporation (OPHT) Reports Second Quarter 2014 Financial Results And Provides Business Update 8/6/2014 9:24:19 AM
12345